Literature DB >> 25696622

Drug-eluting stents not for all patients.

F H de Man, P R Stella, P A Doevendans.   

Abstract

Entities:  

Year:  2006        PMID： 25696622      PMCID： PMC2557237     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  13 in total

1.  Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials.

Authors:  D E Cutlip; D S Baim; K K Ho; J J Popma; A J Lansky; D J Cohen; J P Carrozza; M S Chauhan; O Rodriguez; R E Kuntz
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

2.  Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy.

Authors:  Richard E Waters; David E Kandzari; Harry R Phillips; Lawrence E Crawford; Michael H Sketch
Journal:  Catheter Cardiovasc Interv       Date:  2005-08       Impact factor: 2.692

3.  Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome.

Authors:  Peter Wenaweser; Christoph Rey; Franz R Eberli; Mario Togni; David Tüller; Stefan Locher; Andrea Remondino; Christian Seiler; Otto M Hess; Bernhard Meier; Stephan Windecker
Journal:  Eur Heart J       Date:  2005-02-23       Impact factor: 29.983

4.  The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly.

Authors:  M Monane; R L Bohn; J H Gurwitz; R J Glynn; R Levin; J Avorn
Journal:  Am J Hypertens       Date:  1997-07       Impact factor: 2.689

5.  Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction.

Authors:  Mario Togni; Stephan Windecker; Rosangela Cocchia; Peter Wenaweser; Stephane Cook; Michael Billinger; Bernhard Meier; Otto M Hess
Journal:  J Am Coll Cardiol       Date:  2005-07-19       Impact factor: 24.094

Review 6.  Combination pharmacotherapy for cardiovascular disease.

Authors: 
Journal:  Ann Intern Med       Date:  2005-10-18       Impact factor: 25.391

7.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

8.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

Authors:  Marie-Claude Morice; Patrick W Serruys; J Eduardo Sousa; Jean Fajadet; Ernesto Ban Hayashi; Marco Perin; Antonio Colombo; G Schuler; Paul Barragan; Giulio Guagliumi; Ferenc Molnàr; Robert Falotico
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

9.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

Authors:  Jeffrey W Moses; Martin B Leon; Jeffrey J Popma; Peter J Fitzgerald; David R Holmes; Charles O'Shaughnessy; Ronald P Caputo; Dean J Kereiakes; David O Williams; Paul S Teirstein; Judith L Jaeger; Richard E Kuntz
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

10.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.